Hookworm Treatment Trial for MS Does Not Reduce MRI-Detected Brain Lesions but Alters Immune Profiles
June 18, 2020
Researchers in England and Romania report that administering hookworm treatment into the skin via an arm bandage did not reduce disease activity on MRI scans – the primary goal of the study – but did increase the numbers of regulatory immune cells. This strategy is based on the ”hygiene hypothesis,” which suggests that the reduced exposure to microbes in countries with higher sanitation standards may make the immune system over-react to infections, possibly leading to MS.
In an accompanying editorial, Drs. Daniel Ontaneda and Jeffrey Cohen of the Cleveland Clinic comment that, although this therapy was shown to be safe, its limited effectiveness make it unlikely to become a standalone treatment for MS.
Read more from HealthDay
Read a summary of the paper in JAMA Neurology
The National MS Society, founded in 1946, funds cutting-edge research, drives change through advocacy, and provides programs and services to help people affected by MS live their best lives. Connect to learn more and get involved: nationalMSsociety.org, Facebook, Twitter, Instagram, YouTube or 1-800-344-4867.